Treatment with proton pump inhibitors increases the risk for development of hepatic encephalopathy after implantation of transjugular intrahepatic portosystemic shunt (TIPS)

BACKGROUND AND OBJECTIVE: Treatment with proton pump inhibitors (PPIs) has been associated with development of hepatic encephalopathy (HE). As development of HE is a major complication after implantation of a transjugular intrahepatic portosystemic shunt (TIPS), we hypothesized that PPI treatment ma...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:United European Gastroenterol J
Päätekijät: Sturm, Lukas, Bettinger, Dominik, Giesler, Max, Boettler, Tobias, Schmidt, Arthur, Buettner, Nico, Thimme, Robert, Schultheiss, Michael
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: SAGE Publications 2018
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6206537/
https://ncbi.nlm.nih.gov/pubmed/30386611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640618795928
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia